ARCHIVES

FDA to refer false statements by regulated companies to SEC.

This article is from The Cancer Letter archive.

Vol. 30 No. 09 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

Epstein Back With New Attack On “Establishment” In Congressional Record

November 6, 1987

NCI-Approved Clinical Trials

December 29, 2006

Firm’s Information System Embedded In iKnowMed For Treatment Outcomes.

June 29, 2001

Funding opportunities listed.

September 24, 2004

NCI Health Disparities Center Describes “Think Tank” Projects For Policy Change.

April 27, 2001

Crout Resigns As Director Of FDA Drugs Bureau

July 11, 1980